Sicabalo, Nelito S.
HRN: 25-90-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2024
09/27/2024
IV
500mg
Q8
T/C Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes